Developing a new treatment for syphilis
Alternative Treatment for Syphilis
['FUNDING_OTHER'] · FOX CHASE CHEMICAL DIVERSITY CENTER, INC · NIH-11306916
This study is looking for a new way to treat syphilis, a sexually transmitted infection, and it invites patients to help find a better treatment that could work well for everyone.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FOX CHASE CHEMICAL DIVERSITY CENTER, INC (nih funded) |
| Locations | 1 site (DOYLESTOWN, UNITED STATES) |
| Trial ID | NIH-11306916 on ClinicalTrials.gov |
What this research studies
This research focuses on creating an alternative treatment for syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum. The project aims to identify and develop a new therapeutic agent that could effectively combat this infection. By exploring innovative treatment options, the research seeks to improve patient outcomes and address the limitations of current therapies. Patients may be involved in the research process, contributing to the development of a potentially more effective treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with syphilis who may benefit from alternative treatment options.
Not a fit: Patients who are not diagnosed with syphilis or those who have already received effective treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more effective treatment option for patients suffering from syphilis.
How similar studies have performed: While alternative treatments for syphilis are being explored, this specific approach is novel and has not been extensively tested in prior research.
Where this research is happening
DOYLESTOWN, UNITED STATES
- FOX CHASE CHEMICAL DIVERSITY CENTER, INC — DOYLESTOWN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SMITHGALL, THOMAS E. — FOX CHASE CHEMICAL DIVERSITY CENTER, INC
- Study coordinator: SMITHGALL, THOMAS E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.